MediGene AG
Lochhamer Str. 11
Martinsried
82152
Germany
Tel: 49-89-85 65 29-00
Fax: 49-89-85 65 29-20
Website: http://www.medigene.de/
Email: medigene@medigene.de
282 articles about MediGene AG
-
Medigene Strengthens its Patent Portfolio With a U.S. Patent on a Tagged TCR
2/2/2018
MediGene announces the grant of US patent 9,862,755 by the USPTO covering a high affinity T cell receptor with an epitope tag.
-
Medigene Announces Participation at Six Upcoming Investor and Scientific Conferences
1/19/2018
MediGene today announced its participation at six upcoming investor and scientific conferences.
-
Medigene AG: Expitope 2.0 Helps to Identify Safer Antigens for Immunotherapy of Cancer
1/4/2018
MediGene AG announces that a scientific article has been published in the current issue of "BMC Cancer".
-
Medigene Collaborates With RXi Pharma to Further Sharpen its Therapeutic T cells
12/11/2017
The preclinical research program will examine the applicability of RXi's sd-rxRNA technology to be integrated into Medigene's process to produce receptor-modified T cells with the ultimate goal to further improve Medigene's T cell therapies for the treatment of cancer patients.
-
Medigene Sells U.S.-Rights for Veregen and Raises Financial Guidance 2017
12/6/2017
MediGene today announced the sale of the US-rights for its drug Veregen to Fougera Pharma.
-
Medigene AG: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML
11/27/2017
The completion of the study, as previously announced, is expected in 2019 after a treatment period of two years for all patients.
-
Medigene Reports Nine Months' Results 2017
11/10/2017
MediGene today released its financial results for the first nine months of 2017.
-
Medigene Participates at Six Conferences in November
10/27/2017
Prof. Dolores Schendel, CEO and CSO of Medigene, takes part in the discussion rounds of the "Immuno-Oncology"-Forum on 13 November and will hold a company presentation on 14 November at 12.15 pm.
-
MediGene AG And Academic Partners Publish A Method To Identify T Cell Receptors Against Viral Antigens
10/12/2017
-
MediGene AG And Academic Partners Publish A Method To Enhance Adoptive T-Cell Therapies
6/9/2017
-
MediGene AG: Reports Outcome Of Annual General Meeting And Announces New Supervisory Board Members
5/25/2017
-
MediGene AG: Academic Partner Presented Compassionate Use Data On AML DC Vaccine At AACR Conference
4/5/2017
-
MediGene AG Announces Participation At Six National And International Conferences
3/28/2017
-
MediGene AG: Medigene Revises Collaboration With Mitsui Norin
3/23/2017
-
MediGene AG: Medigene Publishes Its 2016 Annual Report And Outlook For 2017
3/23/2017
-
MediGene AG: Announces Target And Outlines Design For Its First Clinical Trial In TCR Cancer Immunotherapy (MDG1011)
3/23/2017
-
MediGene AG: Medigene Participates At Five National And International Conferences In February And March 2017
2/2/2017
-
MediGene AG Announces Outlicensing Of AAVLP Technology
12/20/2016
-
MediGene AG Participates At Four National And International Conferences In January 2017
12/16/2016
-
MediGene AG To Be Included In TecDAX Index
12/6/2016